HCA: 2Q26 Inline With Preannouncement; 2H26 Puts/Takes In Focus

Research evidence excerpt

HCA: 2Q26 Inline With Preannouncement; 2H26 Puts/Takes In Focus

e securities described herein. We and our affiliates also do business with, or that relates to, companies covered in Guggenheim research

and may have a position in the debt of the company or companies discussed herein.

This research is not an offer to sell or the solicitation of an offer to buy any security. It does not constitute a personal recommendation or take into account

the particular investment objectives, financial situations, or needs of individual clients. Clients should consider whether any advice or recommendation

in this research is suitable for their particular circumstances and, if appropriate, seek professional advice, including tax advice. The price and value of

investments referred to in this research and the income from them will fluctuate. Past performance is not a guide to future performance, future returns are

not guaranteed, and a loss of original capital may occur. Fluctuations in exchange rates could have adverse effects on the value or price of, or income

derived from, certain investments.

This communication does not constitute an offer of Shares to the public in the United Kingdom. No prospectus has been or will be approved in the United

Kingdom in respect of the Securities. Consequently, this communication is directed only at (i) persons who are outside the United Kingdom or (ii) persons

who have professional experience in matters relating to investments falling within Article 19(5) of the Financial Services and Markets Act 2000 (Financial

Promotion) Order 2005 (the “Order”), (iii) high net worth entities falling within Article 49(2) of the Order (iv) and other persons to whom it may lawfully be

communicated (all such persons together being referred to as “relevant persons”).